N-PORT filing recap · March 2025

What did Longleaf Partners Global Fund buy in March 2025?

Reported stock-position changes between this filing and the previous one. These are Longleaf Partners Global Fund's own holdings, not the firm's.

Stock value

$215.62M

Positions

Estimated turnover

21.4%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Period in review

Longleaf Partners Global Fund opened a new position in Regeneron Pharmaceuticals and exited Bollore SE and Prosus NV. It added to Societe D'Edition De Canal Plus, CNX Resources, Mattel, and Glanbia, with the Glanbia increase standing out as substantial. The fund trimmed several holdings, including Fidelity National Information Services, Affiliated Managers Group, Reckitt Benckiser, Eurofins Scientific, and Kraft Heinz.

New positions

REGNRegeneron Pharmaceuticals, Inc.$7.94Mreported value+12.5K shares

Increased positions

CNLPSociete D'Edition De Canal Plus SA$14.93Mreported value+746.7K shares+13.5%PPLIIac Inc.$14.92Mreported value+16.0K shares+5.2%CNXCnx Resources Corporation$14.63Mreported value+85.4K shares+22.5%MATMattel Inc /de/$10.17Mreported value+66.8K shares

Reduced positions

EXOExor NV$13.40Mreported value-16.1K shares-9.9%TIGOMillicom International Cellular SA$13.19Mreported value-5.4K shares-1.2%ACIAlbertsons Companies, Inc.$12.95Mreported value-7.3K shares-1.2%FDXFedex Corporation$11.14Mreported value-568 shares

Exited positions

PROSYProsus NV$8.75Mprior reported value-220.3K shares-100.0%BOLBollore SE$7.44Mprior reported value-1.21M shares-100.0%